◀ Back to ATM

ATM — VWF

Text-mined interactions from Literome

Girma et al., Thromb Haemost 1992 : 125I-vWF binding to ristocetin- and botrocetin treated platelets, to heparin and to sulfatides as well as 125I-botrocetin binding to vWF was competitively inhibited by ATA
LaCroix et al., Thromb Res 1990 : Similar increases in fibrinolytic activity ( FA ), Factor VIII activity ( VIII : C ), von Willebrand factor antigen (vWF:Ag) and plasma catecholamine levels were observed following acute exercise at 1 ATA and at 3 ATA
Ragni et al., Cardiologia 1996 (Acute Disease...) : After CFVs were observed for 30 min, the animals were randomly divided in four groups : 5 animals received via a small catheter ( 26G ) placed proximally to the stenosis, an intra-arterial infusion of human recombinant FVIIai ( 0.1 mg/kg/min for 10 min ) ; 9 animals received AP-1, a monoclonal antibody against rabbit TF ( 0.1 mg/kg i.v. bolus ) ; 7 animals received ridogrel, a dual thromboxane A2 synthetase inhibitor and thromboxane A2 receptor antagonist ( 10 mg/kg i.v. bolus ) ; finally, 8 rabbits received aurintrycarboxilic acid (ATA) , an inhibitor of platelet glycoprotein Ib/von Willebrand factor interaction ( 10 mg/kg i.v. bolus )